GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Bloomage BioTechnology Corp Ltd (SHSE:688363) » Definitions » Forward PE Ratio

Bloomage BioTechnology (SHSE:688363) Forward PE Ratio : 54.62 (As of Jul. 24, 2025)


View and export this data going back to 2019. Start your Free Trial

What is Bloomage BioTechnology Forward PE Ratio?

Bloomage BioTechnology's Forward PE Ratio for today is 54.62.

Bloomage BioTechnology's PE Ratio without NRI for today is 148.86.

Bloomage BioTechnology's PE Ratio (TTM) for today is 913.00.


Bloomage BioTechnology Forward PE Ratio Historical Data

The historical data trend for Bloomage BioTechnology's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bloomage BioTechnology Forward PE Ratio Chart

Bloomage BioTechnology Annual Data
Trend 2021-12 2022-12 2023-12 2024-12
Forward PE Ratio
59.17 47.85 24.69 33.17

Bloomage BioTechnology Quarterly Data
2021-12 2022-03 2022-06 2022-09 2022-12 2023-03 2023-06 2023-09 2023-12 2024-12 2025-03
Forward PE Ratio 59.17 58.14 63.29 44.25 47.85 40.16 33.33 31.35 24.69 33.17 36.39

Competitive Comparison of Bloomage BioTechnology's Forward PE Ratio

For the Specialty Chemicals subindustry, Bloomage BioTechnology's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bloomage BioTechnology's Forward PE Ratio Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Bloomage BioTechnology's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where Bloomage BioTechnology's Forward PE Ratio falls into.


;
;

Bloomage BioTechnology Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.


Bloomage BioTechnology  (SHSE:688363) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .


Bloomage BioTechnology Forward PE Ratio Related Terms

Thank you for viewing the detailed overview of Bloomage BioTechnology's Forward PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Bloomage BioTechnology Business Description

Traded in Other Exchanges
N/A
Address
No. 678 Tianchen Avenue, High-Tech Development Zone, Shandong Province, Jinan City, CHN
Bloomage BioTechnology Corp Ltd manufactures and sells a variety of chemicals and chemical-based products, typically made from hyaluronic acid sodium, or HA. The firm organizes itself into two segments based on product type. The HA raw materials segment, which generates the majority of revenue, sells HA and HA derivatives produced using bio-fermentation technology. The HA raw materials segment products are classified into three grades of HA: medicine grade, cosmetic grade, and food grade. The HA end products segment sells medical skin care products, bone products for intra-articular injection, and medical beauty devices. The majority of revenue comes from China.
Executives
Zhao Yi Core technical personnel
Luan Yi Hong Core technical personnel
Shi Yan Li Core technical personnel
Liu Jian Jian Core technical personnel
Wang Yu Ling Core technical personnel
Zhou Wei Core technical personnel
Huang Si Ling Core technical personnel
Han Hong Ling Core technical personnel
Lu Zhen Core technical personnel

Bloomage BioTechnology Headlines

No Headlines